|
Rheumatoid Arthritis
Summary
Winthrop University Hospital, Clinical Trials Center is conducting a clinical research study to test the effectiveness of the study drug in reducing pain and maintaining movement in joints for participants who are at least 18 years old and diagnosed with active Rheumatoid Arthritis.
Description
The purpose of this research study is to further examine an investigational medication for the treatment of Rheumatoid Arthritis. The study drug is FDA approved as a subcutaneous (under the skin) injection but when given as an IV infusion study drug is investigational (not approved by the FDA).
Inclusion/exclusion
Eligible participants will receive study-related medical examinations, research medication and study-related laboratory tests at no cost, while they are participating in this research study. Compensation may be provided for time and travel. You may be able to participate if you are; ¥ at least 18 years old ¥ diagnosed with Rheumatoid Arthritis ¥ have had inadequate treatment results with other medications
Principal Investigator
Steven Carsons, MD
Department
Clinical Trials Center
Email
Clinicaltrials@winthrop.org
Other Contact
for more information please call: 516-663-9582
|
